Biomarkers and surrogate endpoints in clinical trials von Fleming, Thomas R., Powers, John H.

Volltext

Considerations in boosting COVID-19 vaccine immune responses von Krause, Philip R, Fleming, Thomas R, Peto, Richard, Longini, Ira M, Figueroa, J Peter, Sterne, Jonathan A C, Cravioto, Alejandro, Rees, Helen, Higgins, Julian P T, Boutron, Isabelle, Pan, Hongchao, Gruber, Marion F, Arora, Narendra, Kazi, Fatema, Gaspar, Rogerio, Swaminathan, Soumya, Ryan, Michael J, Henao-Restrepo, Ana-Maria

Volltext

Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial von Giles, Jon T., Sattar, Naveed, Gabriel, Sherine, Ridker, Paul M., Gay, Steffen, Warne, Charles, Musselman, David, Brockwell, Laura, Shittu, Emma, Klearman, Micki, Fleming, Thomas R.

Volltext

Pediatric Pulmonary Hypertension von Ivy, D. Dunbar, MD, Abman, Steven H., MD, Barst, Robyn J., MD, Berger, Rolf M.F., MD, Bonnet, Damien, MD, Fleming, Thomas R., PhD, Haworth, Sheila G., MD, Raj, J. Usha, MD, Rosenzweig, Erika B., MD, Schulze Neick, Ingram, MD, Steinhorn, Robin H., MD, Beghetti, Maurice, MD

Volltext

Idiopathic Pulmonary Fibrosis: Clinically Meaningful Primary Endpoints in Phase 3 Clinical Trials von RAGHU, Ganesh, COLLARED, Harold R, ANSTROM, Kevin J, FLAHERTY, Kevin R, FLEMING, Thomas R, KING, Talmadge E, MARTINEZ, Fernando J, BROWN, Kevin K

Volltext

Conducting Clinical Research During the COVID-19 Pandemic: Protecting Scientific Integrity von Fleming, Thomas R, Labriola, Dominic, Wittes, Janet

Volltext

Issues in Using Progression-Free Survival When Evaluating Oncology Products von FLEMING, Thomas R, ROTHMANN, Mark D, LU, Hong Laura

Volltext

End Points and Clinical Trial Design in Pulmonary Arterial Hypertension von McLaughlin, Vallerie V., MD, Badesch, David B., MD, Delcroix, Marion, MD, PhD, Fleming, Thomas R., PhD, Gaine, Sean P., MD, PhD, Galiè, Nazzareno, MD, Gibbs, J. Simon R., MD, Kim, Nick H., MD, Oudiz, Ronald J., MD, Peacock, Andrew, MD, Provencher, Steeve, MD, MSc, Sitbon, Olivier, MD, Tapson, Victor F., MD, Seeger, Werner, MD

Volltext

New Trial Designs and Potential Therapies for Pulmonary Artery Hypertension von Gomberg-Maitland, Mardi, MD, MSc, Bull, Todd M., MD, Saggar, Rajeev, MD, Barst, Robyn J., MD, Elgazayerly, Amany, MD, PhD, Fleming, Thomas R., PhD, Grimminger, Friedrich, MD, PhD, Rainisio, Maurizio, PhD, Stewart, Duncan J., MD, Stockbridge, Norman, MD, PhD, Ventura, Carlo, MD, PhD, Ghofrani, Ardeschir H., MD, Rubin, Lewis J., MD

Volltext

COVID-19 vaccine trials: The use of active controls and non-inferiority studies von Fleming, Thomas R, Krause, Philip R, Nason, Martha, Longini, Ira M, Henao-Restrepo, Ana-Maria M

Volltext

Addressing Missing Data in Clinical Trials von FLEMING, Thomas R

Volltext

The Effectiveness of NP001 on the Long-Term Survival of Patients with Amyotrophic Lateral Sclerosis von Forrest, Bruce D, Goyal, Namita A, Fleming, Thomas R, Bracci, Paige M, Brett, Neil R, Khan, Zaeem, Robinson, Michelle, Azhir, Ari, McGrath, Michael

Volltext

Issues in Noninferiority Trials: The Evidence in Community-Acquired Pneumonia von Fleming, Thomas R., Powers, John H.

Volltext

Moving forward in IPF: lessons learned from clinical trials von Raghu, Ganesh, Fleming, Thomas R

Volltext

Global Cancer Drug Development-A Report From the 2022 Accelerating Anticancer Agent Development and Validation Meeting von Wilson, Brooke E, Sullivan, Richard, Peto, Richard, Abubakar, Bello, Booth, Christopher, Werutsky, Gustavo, Adams, Cary, Saint-Raymond, Agnes, Fleming, Thomas R, Lyerly, Kim, Gralow, Julie R

Volltext

SARS-CoV-2 Variants and Vaccines von Krause, Philip R, Fleming, Thomas R, Longini, Ira M, Peto, Richard, Briand, Sylvie, Heymann, David L, Beral, Valerie, Snape, Matthew D, Rees, Helen, Ropero, Alba-Maria, Balicer, Ran D, Cramer, Jakob P, Muñoz-Fontela, César, Gruber, Marion, Gaspar, Rogerio, Singh, Jerome A, Subbarao, Kanta, Van Kerkhove, Maria D, Swaminathan, Soumya, Ryan, Michael J, Henao-Restrepo, Ana-Maria

Volltext

Current issues in non-inferiority trials von Fleming, Thomas R.

Volltext

When Can Intermediate Outcomes Be Used as Surrogate Outcomes? von DeMets, David L, Psaty, Bruce M, Fleming, Thomas R

Volltext

Antiretroviral Therapy for the Prevention of HIV-1 Transmission von Cohen, Myron S, Chen, Ying Q, McCauley, Marybeth, Gamble, Theresa, Hosseinipour, Mina C, Kumarasamy, Nagalingeswaran, Hakim, James G, Kumwenda, Johnstone, Grinsztejn, Beatriz, Pilotto, Jose H.S, Godbole, Sheela V, Chariyalertsak, Suwat, Santos, Breno R, Mayer, Kenneth H, Hoffman, Irving F, Eshleman, Susan H, Piwowar-Manning, Estelle, Cottle, Leslie, Zhang, Xinyi C, Makhema, Joseph, Mills, Lisa A, Panchia, Ravindre, Faesen, Sharlaa, Eron, Joseph, Gallant, Joel, Havlir, Diane, Swindells, Susan, Elharrar, Vanessa, Burns, David, Taha, Taha E, Nielsen-Saines, Karin, Celentano, David D, Essex, Max, Hudelson, Sarah E, Redd, Andrew D, Fleming, Thomas R

Volltext

Long-term sildenafil added to intravenous epoprostenol in patients with pulmonary arterial hypertension von Simonneau, Gérald, MD, Rubin, Lewis J., MD, Galiè, Nazzareno, MD, Barst, Robyn J., MD, Fleming, Thomas R., PhD, Frost, Adaani, MD, Engel, Peter, MD, Kramer, Mordechai R., MD, Serdarevic-Pehar, Marjana, MD, Layton, Gary R., MSc, Sitbon, Olivier, MD, PhD, Badesch, David B., MD

Volltext